BOSTON - PerkinElmer Inc. (NYSE: PKI), a leading provider of drug discovery, life science research, and analytical solutions, today announced the introduction of the industry's broadest, scientific eLearning offering. Further demonstrating PerkinElmer's ongoing commitment to key customer needs, eLearning provides organizations with the scalable tools necessary to effectively train employees and improve productivity. As the only fully web-enabled learning solution in the industry, eLearning offers a visually enriched and interactive learning experience that includes tutorials, demos and instructor-led training. The eLearning solution is scalable from 1 to 1,000 employees, and can be customized to match individual skill sets.

Recognizing the need for accessible, customizable training programs that offer substantial customer return on investment, PerkinElmer surveyed more than 40,000 customers to determine specific areas of interest, target audiences and geographic needs. Based on the survey results, PerkinElmer developed its eLearning offering, including thirteen courses in four categories: Scientific Application, Informatics, BioPharma and Biology. In addition to general scientific courses, PerkinElmer will also offer instrument and application specific custom courses in the areas of Atomic Absorption, Inductively Coupled Plasma Optical Emission Spectroscopy, and Chromatography. Additional custom eLearning solutions will be added in the immediate future.

"Our eLearning offering provides the most extensive and diverse content in the life and analytical sciences industry. By creating an offering based on customer feedback, we are certain that eLearning will provide customers with the information and tools necessary to maximize instrument and application investments," said Peter Coggins, Ph.D., president of PerkinElmer Life and Analytical Sciences. "eLearning is the latest addition to our extensive services portfolio and another example of PerkinElmer's commitment to services-an integral aspect of our ongoing business strategy."

To meet the various needs of PerkinElmer's customer base and beyond, PerkinElmer now offers a three-tiered training portfolio that includes classroom training, on-site custom training and eLearning offerings. eLearning is a scalable, cost-effective solution that rounds out PerkinElmer's training offerings. The training courses included in the eLearning offering provide expert design, validated scientific content and the latest technological advancements, ensuring that customers can easily utilize the information learned to maximize productivity while managing training-related costs.

"One of the most exciting aspects of this new offering is our ability to develop best-in-class custom courses," said Coggins. "We feel that our customers will benefit enormously by being able to work with our in-house experts to design a course focused directly to their areas of interest."

Additional information, including a complete list of courses available, can be found online at: http://las.perkinelmer.com/Trainings/CourseSearch.htm.

Factors Affecting Future Performance
This press release contains "forward-looking" statements within the meaning of the Private Securities Litigation Reform Act of 1995. Any statements contained in this press release that relate to prospective events or developments, including, without limitation, all projections of future financial results, are deemed to be forward-looking statements. Words such as "believes," "anticipates," "plans," "expects," "projects," "forecasts," "will" and similar expressions are intended to identify forward-looking statements. There are a number of important risk factors that could cause actual results or events to differ materially from those indicated by these forward-looking statements, including, without limitation, economic and geopolitical forces that may limit any continued or expected economic or end market strengthening or recoveries, risks related to our failure to introduce new products in a timely manner, the impact of our debt on our cash flow and investment opportunities, our ability to comply with financial covenants contained in our credit agreements and debt instruments, cyclical downturns continuing to affect several of the industries into which we sell our products, our ability to adjust our operations to address unexpected changes, our ability to execute acquisitions and license technologies and successfully integrate acquired businesses and licensed technologies into our existing business, the loss of any of our licenses that may require us to stop selling products or lose competitive advantage, competition, regulatory compliance, regulatory changes, our failure to obtain and enforce intellectual property protection, our defense of third party claims of patent infringement and our ability to realize the full value of our intangible assets, as well as other factors which we describe under the caption "Forward-Looking Information and Factors Affecting Future Performance" in our most recent annual report on Form 10-K and in our most recent quarterly report on Form 10-Q, each on file with the Securities and Exchange Commission. We disclaim any intention or obligation to update any forward-looking statements as a result of developments occurring after the date of this press release.

PerkinElmer, Inc. is a global technology leader focused in the following businesses - Life and Analytical Sciences, Optoelectronics and Fluid Sciences. Combining operational excellence and technology expertise with an intimate understanding of our customers' needs, PerkinElmer provides products and services in health sciences and other advanced technology markets that require innovation, precision and reliability. The Company serves customers in more than 125 countries, and is a component of the S&P 500 Index. Additional information is available through www.perkinelmer.com or 1-877-PKI-NYSE.